Ondansetron 70518-3512
Product NDC
70518-3512- Manufacturer
- Remedyrepack Inc.
- Dosage Form
- Tablet, Orally Disintegrating
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- September 7, 2022
- Listing Expires
- December 31, 2027
- Application
- ANDA078152
Need to source Ondansetron? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ondansetron | 4 mg/1 |
Drug Class
Serotonin-3 Receptor Antagonist [EPC]Serotonin 3 Receptor Antagonists [MoA]Serotonin-3 Receptor Antagonist [EPC]
Packaging Options(6)
30 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-0)
6 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-1)
10 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-2)
9 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-5)
15 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-7)
3 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-8)